Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05745051

The Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke

Conditions: Stroke, Stroke, Acute, Stroke, Ischemic, Stroke, Cardiovascular, Stroke Hemorrhagic

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 100

Sponsor: Cvaid Medical

Location: Israel

Summary

The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.

Eligibility Criteria

Inclusion Criteria:Suspected hyper-acute stroke patient at the ED, prior to treatment (tPA or EVT)Age≥18Exclusion Criteria:Intubated patients upon arrivalTime from stroke symptoms onset > 24hPatients post treatment (tPA of EVT)Patient in acute psychosis statePatients who do not speak Hebrew as their mother tongue

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05745051). StuddyBuddy aggregates publicly available trial information.